Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Sulkowski

Showing results (231-240 of 408) with videos related to

Pageof 41
Sort By:
Acta Haematologica Polonica|January 1, 1993
[The study of platelet count and phagocytic activity in experimental hemorrhagic shock. I. Comparison of platelet count in blood of left and right heart ventricles]J Dziecioł, J Osada, H Kemona, et al.
Acta Haematologica Polonica|January 1, 1993
[Study of platelet count and phagocytic activity in experimental hemorrhagic shock. II. Evaluation of phagocytic activity of platelets]J Dziecioł, M Mantur, H Kemona, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United StatesS H Mehta, F L Brancati, M S Sulkowski, et al.
Pneumonologia Polska|April 1, 1989
[Analysis of neoplasm metastases to the bone marrow in patients with lung cancer]J Dziecioł, A Kemona, M Sulik, et al.
Annals of Internal Medicine|March 22, 2016
Antimicrobial Access in the 21st Century: Delays and Critical ShortagesShmuel Shoham, Annukka A R Antar, Paul G Auwaerter, et al.
Journal of Virological Methods|April 10, 2025
High-dimensional droplet digital PCR of multiple hepatitis B splice variants in serum, liver, and tissue cultureTanner Grudda, Chenkai Jiang, Che-Min Lo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2011
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected personsDavid L Thomas, John G Bartlett, Marion G Peters, et al.
Annals of Internal Medicine|March 21, 2017
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic ReviewOluwaseun Falade-Nwulia, Catalina Suarez-Cuervo, David R Nelson, et al.
Neoplasma|January 18, 2006
P53 correlates positively with VEGF in preoperative sera of colorectal cancer patientsW Famulski, M Sulkowska, A Wincewicz, et al.
Prague Medical Report|September 11, 2008
Serum erythropoietin and angiogenetic factors in human colorectal cancerA Chabowska, M Sulkowska, A Wincewicz, et al.
Pageof 41

Showing results (231-240 of 408) with videos related to

Sort By:
Pageof 41
Acta Haematologica Polonica|January 1, 1993
[The study of platelet count and phagocytic activity in experimental hemorrhagic shock. I. Comparison of platelet count in blood of left and right heart ventricles]J Dziecioł, J Osada, H Kemona, et al.
Acta Haematologica Polonica|January 1, 1993
[Study of platelet count and phagocytic activity in experimental hemorrhagic shock. II. Evaluation of phagocytic activity of platelets]J Dziecioł, M Mantur, H Kemona, et al.
Hepatology (Baltimore, Md.)|June 8, 2001
Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United StatesS H Mehta, F L Brancati, M S Sulkowski, et al.
Pneumonologia Polska|April 1, 1989
[Analysis of neoplasm metastases to the bone marrow in patients with lung cancer]J Dziecioł, A Kemona, M Sulik, et al.
Annals of Internal Medicine|March 22, 2016
Antimicrobial Access in the 21st Century: Delays and Critical ShortagesShmuel Shoham, Annukka A R Antar, Paul G Auwaerter, et al.
Journal of Virological Methods|April 10, 2025
High-dimensional droplet digital PCR of multiple hepatitis B splice variants in serum, liver, and tissue cultureTanner Grudda, Chenkai Jiang, Che-Min Lo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2011
Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected personsDavid L Thomas, John G Bartlett, Marion G Peters, et al.
Annals of Internal Medicine|March 21, 2017
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic ReviewOluwaseun Falade-Nwulia, Catalina Suarez-Cuervo, David R Nelson, et al.
Neoplasma|January 18, 2006
P53 correlates positively with VEGF in preoperative sera of colorectal cancer patientsW Famulski, M Sulkowska, A Wincewicz, et al.
Prague Medical Report|September 11, 2008
Serum erythropoietin and angiogenetic factors in human colorectal cancerA Chabowska, M Sulkowska, A Wincewicz, et al.
Pageof 41